Provided is a method of improving urogenital health, including administering to a subject a composition including an effective amount of a Lactobacillus johnsonii strain deposited under the accession number of DSM 33288 or a metabolite thereof. The Lactobacillus johnsonii strain, which is a probiotic, and metabolites thereof inhibit the growth of common pathogenic bacteria and fungi causing genitourinary tract infections, thereby reducing the risk of genitourinary tract infections or alleviating symptoms thereof. Also provided is a composition for improving urogenital health which includes the Lactobacillus johnsonii strain.

The present invention relates to the use of a bacterium of the genus Lactobacillus in the treatment of respiratory diseases in humans as well as in animals. in particular, a particular strain of this bacterium and pharmaceutical compositions comprising it are described.

The present invention relates to a novel isolated and characterised bacterial strain belonging to the species Lacticas- eibacillus rhamnosus, to compositions thereof and to the use thereof in the treatment of genitourinary infections and/or inflammations

Nowadays consumers are looking for “natural” food ingredients for keeping them healthy and fit in all foods. “An Organic Natural Microbial Inhibitor” is an organic antimicrobial ingredient that is synthesized from the fermentation of natural raw materials including rice flour, wheat hydrolysate and corn steep liquor. An amount of 0.1 to 1.5% during preservation of different food products like pickles, salads, beverages, and meat etc., keeps the food free from the microbial contaminations, increases flavor, and meat tenderness. It is produced through co-fermentation of Acetobacter aceti and Lactobacillus delbrueckii that are modified by way of strain improvement through medium optimization experiments. The major ingredients of the product include combination of naturally produced organic acids like acetic, lactic and propionic acids in addition to other acids in trace amounts in liquid form and also in powdered form. These are in combination responsible for the antimicrobial property with simultaneous flavor enhancement.

The present disclosure relates to compositions comprising a plurality of live Lactococcus lactic bacteria and one or more compounds selected from δ-tocotrienol (δTE), γ-tocotrienol (γTE), and/or δTE-13′-carboxychromanol (δTE-13′-COOH, abbr. δTE-13′), and to the method for treating colitis and/or preventing colon cancer live with the novel compositions.

The presently disclosed subject matter relates generally to inexpensive and sustainable compositions and methods to support growth of certain bacteria. In particular, the presently disclosed methods and compositions do not rely on addition of enzymatic components to support the growth of bacteria.

The current invention concerns a feed additive comprising a bacterial culture or a processed bacterial culture and a method for enhancing the zootechnical performance of animals. The bacterial culture comprises an isolated lactic acid bacterium strain, wherein that strain comprises a 16S rRNA sequence exhibiting at least 95% sequence identity to SEQ ID N.sup.o 1.

The present invention relates to a composition suitable for preparing a dairy product comprising at least one starter culture and a Lactobacillus rhamnosus strain capable of imparting onto the dairy product an enhanced creamy flavor without affecting the rheology negatively, the fermentation time or the post-acidification of the dairy product. The present invention further relates to processes for preparing a dairy product, such as a low-fat yogurt or cheese, which has a high content of diacetyl. A Lactobacillus rhamnosus strain useful for preparing such dairy product is also part of the present invention.

The present disclosure relates to novel Lactobacillus sakei WIKIM0109 isolated from kimchi and a composition containing the same. The Lactobacillus sakei WIKIM0109 according to the present disclosure is a lactic acid bacterium having an activity of inhibiting IgG and IgG2a production in blood and an activity of inhibiting IFN-γ, IL-17 and TNF-α production, and can be used in various applications, such as for preventing and ameliorating arthritis or improving intestinal regulation in human or animals.

Provided herein are defined bacterial co-cultures, and methods of generating the same. Further provided are methods of using the defined bacterial co-cultures as probiotics to prevent diseases or disorders in bees and bee colonies.